CLGN
Price
$1.61
Change
-$0.07 (-4.17%)
Updated
Feb 4 closing price
Capitalization
21.08M
56 days until earnings call
Intraday BUY SELL Signals
RZLT
Price
$2.91
Change
-$0.24 (-7.62%)
Updated
Feb 4 closing price
Capitalization
269.84M
6 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLGN vs RZLT

Header iconCLGN vs RZLT Comparison
Open Charts CLGN vs RZLTBanner chart's image
CollPlant Biotechnologies
Price$1.61
Change-$0.07 (-4.17%)
Volume$13.59K
Capitalization21.08M
Rezolute
Price$2.91
Change-$0.24 (-7.62%)
Volume$2.58M
Capitalization269.84M
CLGN vs RZLT Comparison Chart in %
CLGN
Daily Signal:
Gain/Loss:
RZLT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLGN vs. RZLT commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Buy and RZLT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CLGN: $1.61 vs. RZLT: $2.91)
Brand notoriety: CLGN and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 47% vs. RZLT: 29%
Market capitalization -- CLGN: $21.08M vs. RZLT: $269.84M
CLGN [@Biotechnology] is valued at $21.08M. RZLT’s [@Biotechnology] market capitalization is $269.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileRZLT’s FA Score has 1 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • RZLT’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLGN and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLGN’s TA Score shows that 5 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • CLGN’s TA Score: 5 bullish, 5 bearish.
  • RZLT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLGN is a better buy in the short-term than RZLT.

Price Growth

CLGN (@Biotechnology) experienced а -16.58% price change this week, while RZLT (@Biotechnology) price change was -13.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.41%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +32.47%.

Reported Earning Dates

CLGN is expected to report earnings on Apr 02, 2026.

RZLT is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (-2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RZLT($270M) has a higher market cap than CLGN($21.1M). RZLT YTD gains are higher at: 23.305 vs. CLGN (15.000). CLGN has higher annual earnings (EBITDA): -11.37M vs. RZLT (-82.74M). RZLT has more cash in the bank: 152M vs. CLGN (8.55M). RZLT has less debt than CLGN: RZLT (1.45M) vs CLGN (2.94M). CLGN has higher revenues than RZLT: CLGN (2.48M) vs RZLT (0).
CLGNRZLTCLGN / RZLT
Capitalization21.1M270M8%
EBITDA-11.37M-82.74M14%
Gain YTD15.00023.30564%
P/E RatioN/AN/A-
Revenue2.48M0-
Total Cash8.55M152M6%
Total Debt2.94M1.45M202%
FUNDAMENTALS RATINGS
CLGN vs RZLT: Fundamental Ratings
CLGN
RZLT
OUTLOOK RATING
1..100
7781
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6463
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
9085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (21) in the null industry is significantly better than the same rating for CLGN (98) in the Biotechnology industry. This means that RZLT’s stock grew significantly faster than CLGN’s over the last 12 months.

RZLT's Profit vs Risk Rating (100) in the null industry is in the same range as CLGN (100) in the Biotechnology industry. This means that RZLT’s stock grew similarly to CLGN’s over the last 12 months.

RZLT's SMR Rating (98) in the null industry is in the same range as CLGN (99) in the Biotechnology industry. This means that RZLT’s stock grew similarly to CLGN’s over the last 12 months.

RZLT's Price Growth Rating (63) in the null industry is in the same range as CLGN (64) in the Biotechnology industry. This means that RZLT’s stock grew similarly to CLGN’s over the last 12 months.

CLGN's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for RZLT (100) in the null industry. This means that CLGN’s stock grew significantly faster than RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLGNRZLT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 14 days ago
90%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLGN
Daily Signal:
Gain/Loss:
RZLT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTDRF10.00N/A
N/A
Vantage Drilling International Ltd
DTNOF1.68N/A
N/A
DNO ASA
CEVMY21.85N/A
N/A
CTS Eventim AG & Co. KGAA
THLEF302.48-3.18
-1.04%
THALES
GSTMF0.13-0.01
-5.43%
GOLDSTORM METALS CORP.

CLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with SPRO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
-4.17%
SPRO - CLGN
41%
Loosely correlated
+7.01%
CMVLF - CLGN
37%
Loosely correlated
N/A
CLLS - CLGN
33%
Poorly correlated
+0.28%
RZLT - CLGN
31%
Poorly correlated
-7.62%
VTGN - CLGN
30%
Poorly correlated
-3.20%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been closely correlated with QNCX. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if RZLT jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
-7.62%
QNCX - RZLT
83%
Closely correlated
+9.28%
TPST - RZLT
82%
Closely correlated
-1.24%
BCAB - RZLT
79%
Closely correlated
+11.06%
GNTA - RZLT
75%
Closely correlated
-1.27%
BDRX - RZLT
73%
Closely correlated
-11.04%
More